Company / Shares Outstanding
CRISPR Therapeutics AG Shares Outstanding History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
85.7M
FY2025
5-year range
73.9M / 85.7M
FY2021-FY2025
Trend
+7.1%
vs FY2024
Sector context
#112 of 212
Health Care
What the data says
At 85741981.00, CRISPR Therapeutics AG's shares outstanding ranks #101 of 212 in the Health Care sector. Shares Outstanding has increased for 9 consecutive years, from 5528079.00 in FY2016 to 85741981.00 in FY2025.
Based on SEC 10-K filings.
85741981.00 in FY2025 with a 5-year CAGR of +7.1%.
Increased from 78512450.00 to 85741981.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +3.7%
- 5-Year CAGR
- +7.1%
- 10-Year CAGR
- -
Sector benchmark
#101 of 212 in Health CareTop 47% of 212This company 85.7M Sector average 306.3M
▼
-72.0% below sector average
Key checks
Key Insights
- CRISPR Therapeutics AG's shares outstanding has grown for 9 consecutive years.
- In FY2025, shares outstanding increased 7.1% year-over-year.
- Ranks #112 out of 212 companies in the Health Care sector.
- Lowest shares outstanding in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 85.7M | +7.1% |
| FY2024 | 80.0M | +2.0% |
| FY2023 | 78.5M | +2.0% |
| FY2022 | 77.0M | +4.2% |
| FY2021 | 73.9M | +21.6% |
| FY2020 | 60.8M | +17.2% |
| FY2019 | 51.9M | +27.7% |
| FY2018 | 40.6M | +2.2% |
| FY2017 | 39.7M | +618.5% |
| FY2016 | 5.5M | +9.7% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026